PDF(1676 KB)
D-柠檬烯对胶质母细胞瘤细胞增殖的抑制作用及其机制
王腾飞, 陈凤, 齐玲, 雷婷, 宋美慧
PDF(1676 KB)
PDF(1676 KB)
D-柠檬烯对胶质母细胞瘤细胞增殖的抑制作用及其机制
Inhibitory effect of D-limonene on proliferation of glioblastoma cells and its mechanism
目的 探讨D-柠檬烯对胶质母细胞瘤(GBM)细胞增殖和凋亡的影响,并阐明其可能的作用机制。 方法 将GBM细胞分为对照组(0 mmol·L-1 D-柠檬烯)和0.2、 0.4、 0.6、 0.8及1.0 mmol·L-1 D-柠檬烯组。采用CCK-8法检测各组细胞增殖抑制率,克隆形成法检测各组细胞克隆形成率,Annexin Ⅴ-FITC/PI法检测各组细胞凋亡率,Western blotting法检测各组细胞中蛋白激酶B(AKT)、B细胞淋巴瘤2(Bcl-2)、Bcl-2相关X蛋白(Bax)和多聚二磷酸腺苷(ADP)核糖聚合酶(PARP)蛋白表达水平,免疫荧光法检测各组细胞中裂解的半胱氨酸天冬氨酸蛋白酶(cleaved Caspase)-3 蛋白表达水平。15 只建立皮下移植瘤模型小鼠随机分为空白组(0 mg·kg-1·d-1 D-柠檬烯)、低剂量D-柠檬烯组(200 mg·kg-1·d-1 D-柠檬烯)和高剂量D-柠檬烯组(400 mg·kg-1·d-1 D-柠檬烯),每组5只。计算各组小鼠体内肿瘤抑制率,HE染色和免疫组织化学染色观察各组小鼠皮下肿瘤组织形态表现,并绘制肿瘤生长曲线,免疫组织化学法检测各组小鼠皮下瘤组织中Ki67蛋白阳性表达率,TUNEL染色法检测各组小鼠肿瘤细胞凋亡情况。 结果 对照组细胞呈长梭形,状态良好,紧密且贴壁生长,细胞器和细胞质正常;给药48 h后,0.6 mmol·L-1 D-柠檬烯组细胞体积减小,细胞膜虽完整但通透性增强,细胞质皱缩,细胞内部产生空泡结构,部分呈碎片状漂浮在溶液表面;0.8 和1.0 mmol·L-1 D-柠檬烯组细胞中有明显凋亡小体生成,呈现凋亡状态。CCK-8法,与对照组比较,0.6、0.8和1.0 mmol·L-1 D-柠檬烯组U87、LN229及GL261细胞增殖抑制率均明显升高(P<0.01),0.4 mmol·L-1 D-柠檬烯组U87和GL261细胞增殖抑制率均明显升高(P<0.01)。克隆形成法,与对照组比较,0.4、0.6和0.8 mmol·L-1 D-柠檬烯组U87、LN229及GL261细胞克隆形成率均明显降低(P<0.05或P<0.01)。Annexin Ⅴ-FITC/PI法,与对照组比较,D-柠檬烯处理48 h后,0.6、0.8和1.0 mmol·L-1 D-柠檬烯组LN229细胞凋亡率明显升高(P<0.01)。Western blotting法,与对照组比较,0.6、0.8和1.0 mmol·L-1 D-柠檬烯组LN229细胞中Bax蛋白表达水平均明显升高(P<0.01),AKT和Bcl-2蛋白表达水平均明显降低(P<0.01);0.8和1.0 mmol·L-1 D-柠檬烯组LN229细胞中PARP蛋白表达水平均明显升高(P<0.01)。免疫荧光法,与对照组比较,0.6、0.8和1.0 mmol·L-1 D-柠檬烯组LN229细胞中cleaved Caspase-3蛋白表达水平均明显升高(P<0.01)。与空白组比较,低和高剂量D-柠檬烯组小鼠肿瘤体积均明显减小(P<0.01)。与空白组比较,低和高剂量D-柠檬烯组小鼠肿瘤质量均明显降低(P<0.05),肿瘤抑制率均明显升高(P<0.05)。空白组小鼠肿瘤细胞弥漫分布,细胞核染色加深,核浆比增大;低和高剂量D-柠檬烯组小鼠肿瘤组织出现大量肿瘤细胞变性坏死。与空白组比较,低和高剂量D-柠檬烯组小鼠肿瘤组织中Ki67蛋白阳性表达率均明显降低(P<0.01)。与空白组比较,低和高剂量D-柠檬烯组小鼠肿瘤细胞凋亡率均明显升高(P<0.01)。 结论 D-柠檬烯具有抑制GBM细胞增殖的作用,其作用机制可能与调控AKT蛋白的表达并激活Caspase-3通路诱导凋亡有关。
Objective To discuss the effect of D-limonene on the proliferation and apoptosis of the glioblastoma (GBM) cells,and to clarify its possible mechanism. Methods The GBM cells were divided into control group (0 mmol·L-1 D-limonene) and 0.2, 0.4, 0.6, 0.8, and 1.0 mmol·L-1 D-limonene groups. CCK-8 method was used to detect the inhibitory rates of proliferation of the cells in various groups; clone formation assay was used to detect the clone formation rates of the cells in various groups; Annexin Ⅴ-FITC/PI method was used to detect the apoptotic rates of the cells in various groups; Western blotting method was used to detect the expression levels of protein kinase B (AKT), B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), and poly adenosine diphosphate(ADP)-ribose polymerase (PARP) proteins in the cells in various groups; imunofluorescence method was used to detect the expression levels of cleaved Caspase-3 protein in the cells in various groups. Fifteen model mice with subcutaneous tumor xenografts were randomly divided into blank group (0 mg·kg-1·d-1 D-limonene), low dose of D-limonene group (200 mg·kg-1·d-1 D-limonene), and high dose of D-limonene group (400 mg·kg-1·d-1 D-limonene), and there were 5 mice in each group.The inhibitory rates of the tumor in vitro in various groups were calculated; HE staining and immunohistochemical staining were used to observe the morphology of subcutaneous tumor tissue of the mice in various groups and the growth curves of the tumor were drawn; immunohistochemical assay was used to detect the positive expression rates of Ki67 protein in subcutaneous tumor tissue of the mice in various groups; TUNEL staining was used to detect the apoptosis of the tumor cells in various groups. Results In control group, the cells were spindle-shaped, in good condition, growing closely and adherently, with normal organelles and cytoplasm. After treated for 48 h, the cells in 0.6 mmol·L-1 D-limonene group showed reduced volume, intact but more permeable cell membranes, shrunken cytoplasm, internal vacuole structures, and some fragments floating in the solution. The cells in 0.8 and 1.0 mmol·L-1 D-limonene groups exhibited significant apoptotic bodies and were in an apoptotic state. The CCK-8 results showed that compared with control group, the inhibitory rates of proliferation of the U87, LN229, and GL261 cells in 0.6, 0.8, and 1.0 mmol·L-1 D-limonene groups were significantly increased (P<0.01), the inhibitory rates of proliferation of the U87 and GL261 cells were significantly increased (P<0.01). The clone formation assay results showed that compared with control group, the clone formation rates of the U87, LN229, and GL261 cells in 0.4, 0.6, and 0.8 mmol·L-1 D-limonene groups were significantly decreased (P<0.05 or P<0.01). The Annexin Ⅴ-FITC/PI results showed that compared with control group, after treated with D-limonene for 48 h, the apoptotic rates of the LN229 cells in 0.6, 0.8, and 1.0 mmol·L-1 D-limonene groups were significantly increased (P<0.01). The Western blotting results showed that compared with control group, the expression levels of Bax proteins in the LN229 cells in 0.6, 0.8, and 1.0 mmol·L-1 D-limonene groups were significantly increased (P<0.01), while the expression levels of AKT and Bcl-2 proteins were significantly decreased (P<0.01), the expression level of PARP protein in the LN229 cells in 0.8 and 1.0 mmol·L-1 D-limonene group was significanthy increased(P<0.01).The immunofluorescence results showed that compared with control group, the expression levels of cleaved Caspase-3 protein in the LN229 cells in 0.6, 0.8, and 1.0 mmol·L-1 D-limonene groups were significantly increased (P<0.01). Compared with blank group, the tumor volumes of the mice in low and high doses of D-limonene groups were significantly decreased (P<0.01). Compared with blank group, the tumor weights of the mice in low and high doses of D-limonene groups were significantly decreased (P<0.05), and the inhitory rates of tumor were significantly increased (P<0.05). The tumor cells in blank group were diffusely distributed, with deepened nuclear staining and increased nucleocytoplasmic ratio; a large number of degenerated and necrotic tumor cells were observed in tumor tissue of the mice in low and high doses of D-limonene groups. Compared with blank group, the positive expression rates of Ki67 protein in tumor tissue of the mice in low and high doses of D-limonene groups were significantly decreased (P<0.01). Compared with blank group, the apoptotic rates of tumor cells of the mice in low and high doses of D-limonene groups were significantly increased (P<0.01). Conclusion D-limonene has the inhibitory effect on the proliferation of the GBM cells; its mechanism may be related to the regulation of AKT protein expression and the activation of the Caspase-3 pathway to induce the apoptosis.
D-柠檬烯 / 胶质母细胞瘤 / 细胞凋亡 / 移植瘤 / 蛋白激酶B
D-limonene / Glioblastoma / Apoptosis / Transplantation tumor / Protein kinase B
R739.4
| 1 | MA R C, TAPHOORN M J B, PLAHA P. Advances in the management of glioblastoma[J]. J Neurol Neurosurg Psychiatry, 2021, 92(10): 1103-1111. |
| 2 | LOUIS D N, GIANNINI C, CAPPER D, et al. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant[J]. Acta Neuropathol, 2018, 135(4): 639-642. |
| 3 | SCHAFF L R, MELLINGHOFF I K. Glioblastoma and other primary brain malignancies in adults: a review[J]. JAMA, 2023, 329(7): 574-587. |
| 4 | PAGE C, LIN H J, JIN Y, et al. Overexpression of akt/AKT can modulate chemotherapy-induced apoptosis[J]. Anticancer Res, 2000, 20(1A): 407-416. |
| 5 | JIA S S, XI G P, ZHANG M, et al. Induction of apoptosis by D-limonene is mediated by inactivation of Akt in LS174T human colon cancer cells[J]. Oncol Rep, 2013, 29(1): 349-354. |
| 6 | LEITE-ANDRADE M C, DE ARAúJO NETO L N, BUONAFINA-PAZ M D S, et al. Antifungal effect and inhibition of the virulence mechanism of D-limonene against Candida parapsilosis[J]. Molecules, 2022, 27(24): 8884. |
| 7 | LI Y, LIU S T, ZHAO C, et al. The chemical composition and antibacterial and antioxidant activities of five citrus essential oils[J]. Molecules, 2022, 27(20): 7044. |
| 8 | JUSTINO DE ARAúJO A C, FREITAS P R, RODRIGUES DOS SANTOS BARBOSA C, et al. GC-MS-FID characterization and antibacterial activity of the Mikania cordifolia essential oil and limonene against MDR strains[J]. Food Chem Toxicol, 2020, 136: 111023. |
| 9 | BERLIOCCHI L, CHIAPPINI C, ADORNETTO A, et al. Early LC3 lipidation induced by d-limonene does not rely on mTOR inhibition, ERK activation and ROS production and it is associated with reduced clonogenic capacity of SH-SY5Y neuroblastoma cells[J]. Phytomedicine, 2018, 40: 98-105. |
| 10 | AFSHORDEL S, KERN B, CLASOHM J, et al. Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation: impact of Ras-/ Rho-prenylation[J]. Pharmacol Res, 2015, 91: 69-77. |
| 11 | MA Y, BIAN J M, ZHANG F. Inhibition of perillyl alcohol on cell invasion and migration depends on the Notch signaling pathway in hepatoma cells[J]. Mol Cell Biochem, 2016, 411(1/2): 307-315. |
| 12 | KAJI I, TATSUTA M, IISHI H, et al. Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association[J]. Int J Cancer, 2001, 93(3): 441-444. |
| 13 | CHAUDHARY S C, SIDDIQUI M S, ATHAR M, et al. D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis[J]. Hum Exp Toxicol, 2012, 31(8): 798-811. |
| 14 | LU X G, ZHAN L B, FENG B G, et al. Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene[J]. World J Gastroenterol, 2004, 10(14): 2140-2144. |
| 15 | SONG X G, XIE L, WANG X W, et al. Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer[J]. Sci Rep, 2016, 6: 22762. |
| 16 | ZHANG X Z, WANG L, LIU D W, et al. Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803[J]. J Med Food, 2014, 17(9): 955-962. |
| 17 | YU X, LIN H Y, WANG Y, et al. D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer[J]. Onco Targets Ther, 2018, 11: 1833-1847. |
| 18 | TSAI P J, LAI Y H, MANNE R K, et al. Akt: a key transducer in cancer[J]. J Biomed Sci, 2022, 29(1): 76. |
| 19 | CUI B B, TAO J, YANG Y M. Studies on the expression patterns of class Ⅰ PI3K catalytic subunits and its prognostic significance in colorectal cancer[J]. Cell Biochem Biophys, 2012, 62(1): 47-54. |
| 20 | YU L, WEI J, LIU P D. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer[J]. Semin Cancer Biol, 2022, 85: 69-94. |
| 21 | CAGGIA S, CHUNDURI H, MILLENA A C, et al. Novel role of Giα2 in cell migration: downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells[J]. J Cell Physiol, 2018, 234(1): 802-815. |
/
| 〈 |
|
〉 |